NASDAQ
Eucrates Biomedical Acquisition Corp. (EUCR) has a fcf yield of -2.12% as of Friday, May 29, 2026. This represents a 145.28% decrease compared to its 12-month average of -0.86%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.